Bottom line is....the company is developing a treatment for cervical cancer. the technology is sound, and the phase 2b results were great.
My view is that this should be the driver behind an increased SP.
The anticipation of a NASDAQ listing has clearly overshadowed the promising clinical results.
How unfortunate...share price should be a lot higher. Seriously undervalued stock.
- Forums
- ASX - By Stock
- who cares about nasdaq
Bottom line is....the company is developing a treatment for...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $566.5M |
Open | High | Low | Value | Volume |
39.0¢ | 39.5¢ | 38.5¢ | $997.5K | 2.559M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 85852 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 75389 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 82255 | 0.385 |
9 | 274350 | 0.380 |
3 | 35464 | 0.375 |
5 | 94020 | 0.370 |
2 | 11078 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 75389 | 4 |
0.395 | 44264 | 2 |
0.400 | 176281 | 6 |
0.405 | 187434 | 3 |
0.410 | 296117 | 10 |
Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |